Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
1.060
-0.060 (-5.36%)
At close: Dec 5, 2025, 4:00 PM EST
1.050
-0.010 (-0.93%)
After-hours: Dec 5, 2025, 7:36 PM EST
Lexaria Bioscience Employees
Lexaria Bioscience had 7 employees as of August 31, 2025. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$100,846
Profits / Employee
-$1,700,263
Market Cap
23.56M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
LEXX News
- 23 days ago - Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended - Accesswire
- 2 months ago - Lexaria Bioscience Corp. Provides Strategic Update - Accesswire
- 2 months ago - Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Accesswire
- 2 months ago - Lexaria Bioscience Corp. Announces $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - TheNewswire
- 2 months ago - Lexaria's Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain - Accesswire
- 3 months ago - Lexaria Attending the 27th Annual H.C. Wainwright Global Investment Conference - TheNewswire
- 4 months ago - Lexaria's Phase 1b GLP-1 Study Achieves Important "Last Patient Last Visit" Milestone - Accesswire
- 4 months ago - GLP-1 "Arms Race" Broadens to Include Dozens of Companies - Accesswire